Depression, anxiety, and obesity

Similar documents
Clinical Staging for Obesity. Raj Padwal Clinical Pharmacology and General Internal Medicine University of Alberta

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.

Dr.Kamal Waheeb AlGhalayini MD, SCC Med. MSc-Card Associate professor, Consultant Cardiology. Head non-invasive lab. Vice dean for clinical affaires

Access to Proven Therapies

Obesity: Pharmacologic and Surgical Management

5As Team learning modules. Assessment of patient readiness to change is an important step in addressing weight

WEIGHT LOSS SURGERY A Primer on Current Options and Outcomes. Caitlin A. Halbert DO, MS, FACS, FASMBS April 5, 2018

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity

The Growing Epidemic of Diabetes

Obesity and Cancer Survivorship. Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona

Not over when the surgery is done: surgical complications of obesity

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity

Kerri Wade, RN, MSN, PPCNP-BC Children s Mercy APRN Annual Conference October 7, The Children's Mercy Hospital, 2016

Learning To Lean On Others

«Πατσζαρκία και Καρδιαγγειακή Νόζος»

Nutrition in the twenty-first century

OBESITY:Pharmacotherapy Vs Surgery

25/10/2017. Obesity Treatment Pyramid. Australian s BMI - 28% are obese. Bariatric-Metabolic Surgery: What the GP needs to know

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Obese Patients & Bariatric Surgery

OBESITY. SEARCH Program Southwest Community Health Center Grace Hwang, RN, SPNP Yale University SON

Obesity and Cancer Survivorship: Where are we in Providing Care? Cynthia Thomson, PhD, RD Mary Koithan, PhD, RN, CNS-BC

Which Weigh to Go? Behavior and Dietary Strategies for Weight Management March 7, 2013

Measuring the Impact of Improved Coverage for Obesity Treatment. Ted Kyle, RPh, MBA

Surgical Therapy for Morbid Obesity. Janeen Jordan, PGY 5 Surgical Grand Rounds April 7, 2008

Dr. Shahebina Walji MD. Clinical Lecturer, University of Calgary Medical Director, Calgary Weight Management Centre

Case Studies in Value-Based Benefit Design. Results and Lessons Learned. Jerry Reeves MD HEREIU Welfare Funds Health Innovations

Weight Regulation after Bariatric Surgery

To Cut or Not To Cut Can Surgery Provide a Better Solution?

Selected Overweight- and Obesity- Related Health Disorders

Reducing the Health Impact of Obesity Why Is This So Hard? Ted Kyle, RPh, MBA

Critical Analysis of Popular Diets and Supplements

Pete Avara, MD, FACS South Mississippi Surgical Weight Loss Center

Science of Obesity (I-2.28)

Neurophysiology and pharmacology of obesity

Empower Preventive Medicine. Timothy J. McCormick, DO, MPH 4221 Baymeadows Suite 6 Jacksonville, FL

Department of Psychiatry & Behavioral Sciences. University of Texas Medical Branch

The Obesity Epidemic: Its Impact in the Workplace and What Employers Can Do

Morbid Obesity A Curable Disease?

ERIC J. NESTLER, MD, PhD

BNORC: Contribution over 25 years to evidence on obesity and cancer

Treating Depression in Disadvantaged Women: What is the evidence?

Supplementary Online Content

ACHIEVING HEALTH: AGENDA: Achieving Health: A Look at Your Weight Management Options

UNDERSTANDING TYPE 2 DIABETES

SURGICAL MANAGEMENT OF OBESITY. Anne Lidor, MD, MPH Professor of Surgery Chief, Division of Minimally Invasive and Bariatric Surgery

Disclosures. Faculty: Brian Stonehocker, MD, FRCPC. Relationships with commercial interests: Speakers Bureau: Shire, Lundbeck, Lilly

Bariatric Surgery: A Cost-effective Treatment of Obesity?

RESIST Dietary strategies to improve insulin sensitivity in overweight adolescents

Bariatric Surgery: The Primary Care Approach

Clinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant

Chairman s Rounds, 02/15/2011

How much do you know about illnesses or health problems for your parents, grandparents, brothers, sisters, and/or children? 1 A lot Some None at all

Strategies in Weight Management

Pharmacotherapy Handbook

BIOLOGICAL D E T E R M I N AN T S O F H E AL T H ( )

Does cymbalta cause weight gain

OVERWEIGHT AND OBESITY. Dharma Lindarto Div. Endokrin-Metabolik Departemen Penyakit Dalam FK USU/RSUP H Adam Malik Medan.

Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Antidepressants. Professor Ian Jones May /WalesMentalHealth

Introducing the Physical Activity Guidelines for Americans, 2 nd edition

Disclosures. Obesity and Its Challenges: Outline. Outline 5/2/2013. Lan Vu, MD Division of Pediatric Surgery Department of Surgery

HE 250 PERSONAL HEALTH. Fitness

Effective Treatment of Depression in Older African Americans: Overcoming Barriers

The Obesity Epidemic. John Ganser, MD, FACS Associate Professor UNSOM.

ASMBS Conference 2015

FROM MEDICATION TO MINDFULNESS: NEW INSIGHTS INTO THE WORLD OF ANXIETY

Statement of Objectives:

Comorbid Conditions and Antipsychotic Use in Patients with Depression

Can Diabetes Be Cured? Tiffany Beckman M.D., M.P.H.

Antidepressant Medication Therapy in Primary Care July 25, 2013

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.

Diet & Healthy Living

Diabetes and Obesity Choose To Change A Tier 3 Weight Management Service ABL Health. Dr Sheena Bedi: Chief Executive

Common Antidepressant Medications for Adults

What You Should Know and What You Can Do to Stay Healthy

Advancing Behavioral and Social Sciences Research to Meet the Challenges of Obesity and Diabetes

Patient Assessment for Bariatric Surgery A diagnostic tool from ModernMedicine.com

SUPPLEMENTARY MATERIAL

I have no conflicts of interest to disclose

Making Changes: Cognitive Behavior Therapy for Binge Eating Disorder. Michele Laliberte, Ph.D., C.Psych.

ANTIDEPRESSANT MEDICATION & RISK OF DEMENTIA

Biochemistry of Nutrition. Prof K Syed Department of Biochemistry & Microbiology University of Zululand Room no. 247

Antidepressant Selection in Primary Care

Depression in Late Life

OVERVIEW OF NUTRITION & HEALTH

The Impact of Insulin Resistance on Long-Term Health in PCOS

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Dr.Rahiminejad Roozbeh Hospital TUMS

Information Management. A System We Can Count On. Chronic Conditions. in the Central East LHIN

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD

Depression in the Medically Ill

Depression major depressive disorder. Some terms: Major Depressive Disorder: Major Depressive Disorder:

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

Summary of Strategic Competitive Analysis and Publication Planning

Primary Care Management of Depression. John Briles, MD, Medical Director October 11, 2017

Medical Reference Library Table of Contents

Transcription:

Depression, anxiety, and obesity 5As Team Learning modules Depression and anxiety are two prevalent mood disorders that affect Canadians, with as many as 40-70% of overweight/obese individuals at high risk of depression. When consulting and treating patients with obesity, it is important to take a holistic approach using a biological, psychological and social evaluation of their health. Obesity is a chronic condition that encompasses a variety of causes and complications, and mental illness is unique in that it has potential to be both a cause and a complication. As a primary care health practitioner, it is important to learn to recognize your patients risk factors for depression and anxiety disorders. Understanding how these conditions are linked to obesity will go a long way when tailoring your treatment and management plan for each individual patient. Dr. Brian Stonehocker is an assistant clinical professor and residency program director in the University of Alberta Department of Psychiatry. As a practicing psychiatrist and consultant to the Alberta Health Services Weight Wise program, Dr. Stonehocker has worked on several projects looking at the relationship between mental health and obesity. His primary area of expertise is in consultation liaison psychiatry, the branch of psychiatry that specializes in the interface between medicine and psychiatry. This module contains: A link to the video on depression, anxiety, and obesity o https://www.youtube.com/watch?v=-2klrjassmm A PowerPoint presentation (page 2-32) that covers the following topics: o o o o The aetiology and determinants of obesity Medical complications of obesity Mental health as a cause of obesity and barrier to effective management Obesity as a risk factor for depression and anxiety disorders The role of antidepressant therapy in weight gain A discussion guide for further reflection (page 33)

Mood and Food Dr. Brian Stonehocker University of Alberta Department of Psychiatry Alberta Health Services Weight Wise 2

www.obesitynetwork.ca 3

Weight Distribution in the Canadian Population Men Women 50 45 44* 42 % 40 35 30 34 30* 25 20 15 17 14 10 5 0 1 E 3* Underweight Normal weight Overweight (not obese) Obese Class I 5 6 Obese Class II 2 4* Obese Class III Data from: Statistics Canada. 4

Medical Complications of Obesity Pulmonary Disease abnormal function obstructive sleep apnea hypoventilation syndrome Nonalcoholic Fatty Liver Disease steatosis steatohypatitis cirrhosis Idiopathic Intracranial Hypertension Stroke Cataracts Accelerated Atherosclerosis Coronary Heart Disease Diabetes Dyslipidemia Gall Bladder Disease Gynecologic Abnormalities abnormal menses infertility polycystic ovarian syndrome Osteoarthritis Hypertension Severe Pancreatitis Cancer breast, uterus, cervix, colon, esophagus, pancreas, kidney, prostate Skin Gout Phlebitis venous stasis 5

Edema = Positive Fluid Balance Sharma & Padwal, Obes Rev 2009 6

X Fluid In X Fluid Out Sharma & Padwal, Obes Rev 2009 7

X Energy In X Energy Out Sharma & Padwal, Obes Rev 2009 8

Diabetes Cardiovascular HTN Disease Osteoarthritis Sleep Apnea 9

Obesity Obesity 10

Obesity Obesity 11

Diabetes Cardiovascular Disease HTN 12

Bariatric Surgery: Effect on Cardiovascular Risk A Systematic Review and Meta-Analysis of 22,090 Patients Hypertension Dyslipidemia Diabetes Sleep Apnea % resolved 62% 70% 77% 86% Buchwald H, et al. JAMA 2004;292:1724 13

Obesity Obesity 14

Obesity Obesities 15

An Aetiological Framework for Obesity IN OUT Diet Metabolism Activity SOCIO-CULTURAL BIOMEDICAL Homeostatic hyperphagia MENTAL Hedonic hyperphagia MEDICATIONS prednisone etc. AGE GENDER GENETICS HORMONES SKELETAL MUSCLE MEDICATIONS WEIGHT LOSS SOCIO-CULTURAL BIOMEDICAL Osteoarthritis, stroke etc. MENTAL Depression, social phobia MEDICATIONS beta-blockers etc. 16 Sharma A, Padwal R. Obesity Reviews, 2009

Mental Health as a Root Cause of Obesity Altered Metabolism Medications Increased Intake Disordered Eating ADHD Mood and Anxiety PTSD/Abuse Medications Reduced Activity Depression Medication 17

Mental Health as a Barrier to Obesity Management Reduced Capacity to Manage Change Concentration Mood Organizational Skills Motivation Energy 18

Mood Disorders: A Risk Factor for Metabolic Disturbance Diabetes mellitus and obesity are twice as prevalent in patients with mood disorders than control populations Insulin resistance leading to glucoregulatory disturbances may mediate cardiovascular, osteoporosis, cognitive abnormalities in mood disorders Bidirectional link between mood disorders and diabetes control 19 McIntyre RS, et al. Ann Clin Psychiatry. 2007 Oct-Dec;19(4):257-64

Depression in General Medical Conditions HIV/AIDs 5 20% Coronary Artery Disease 16 19% Cerebrovascular Disease (stroke) 25 30% Parkinson's Disease 28 51% Epilepsy 20 55% Various Cancers 5 20% Diabetes Mellitus 20-40% Overweight/Obesity 40-70% 20

Psychiatric Diagnoses in Patients Seeking Obesity Treatment Kessler RC. Arch of Gen Psychiatry, 2005 21

Depression Many studies have documented a relationship between obesity and and increased risk of depression Stronger association for women Higher rates of depression in people seeking obesity treatment than in the community 22

Does Obesity Lead to Depression? Several prospective studies have shown increased rates of depression when obese patients are followed over time Obesity at baseline increased the risk of onset of depression at follow-up OR 1.55; (95% CI 1.22-1.98) Luppino, FS et. Al. Arch Gen Psychiatry 2010 Mar 23

Does treating Obesity cause Remission of Depression? Some patients may have improved mood with weight loss Fewer pain, physical symptoms Improved self esteem Pre-existing mood disorders often persist with weight loss Jones-Corneille et al, Obesity Management, 2007 24

Evaluation of Depressed Mood Biological Psychological Social 25

Weight Gain with Antidepressants 26

Weight Gain Differential Improvement in patients who lost weight secondary to depression Residual symptom (overeat when depressed) Side Effect Significant gain in acute phase Gain continues despite remission 27

Weight Change (kg) 6 5 4 3 2 1 0-1 -2-3 Weight Change During Maintenance Antidepressant * Treatment (>4 months) * * * * 13.2 11.0 8.8 6.6 4.4 2.2 0-2.2-4.4-6.6 Weight Change (lb) * Filled squares indicate a significant effect. 28 Adapted from Serretti et al, J Clin Psych 71:10 2010.

Weight Gain MAOI s Very common side effect Less likely with reversible MAOI s (ie moclobemide) Tricyclics Gain an average of 1.3 to 2.9 lbs per month in first year 29

Weight Gain SSRI s Initially viewed as weight neutral or associated with weight loss Long term suggest an increase in weight Paroxetine more likely to cause weight gain than Fluoxetine and Sertraline 30

Weight Gain SNRI s Venlafaxine Desvenlafaxine Duloxetine All relatively weight neutral 31

Weight Gain Mirtazipine (Remeron) Antihistamine Significant weight gain Bupropion (Wellbutrin) Slight weight loss overall 32

Discussion guide This is a guide for questions and topics to consider after viewing Dr. Stonehocker s video and slide show on the topic of Depression, Anxiety, and Obesity. These questions may be discussed in a group or on your own. 1. Please take a moment on your own and consider what are the key messages you took from the speaker today (tips, messages, tools)? o Of the information presented how do you see yourself applying it in your practice? o Were you surprised by the evidence suggesting a correlation between obesity and depression? Why or why not? o What are some concerns that you have regarding the treatment options for patients with chronic mental illness? Are there any alternatives? o How do these concerns change the way you approach patients seeking mental health support? And for patients seeking obesity treatment? o What are some ways that we can proactively address mental health risks before they become a comorbid health problem? o Is there anything you would like to learn more about on this topic? 2. Goal Setting o Take a few moments of quiet time to come up with your own goal concerning a change you feel you can implement in your practice regarding mental health and obesity. o Can you anticipate difficulties in achieving this goal? o Are you confident that you can reach your goal? 2